Effects on Subacute Stroke With Robotic Assistive Gait Training
NCT ID: NCT07040215
Last Updated: 2025-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2025-07-01
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
\- Does RAGT combined with traditional physical therapy improve gait and functional performance in subacute stroke patients compared to traditional physical therapy alone? Participants who are subacute stroke patients will be randomly assigned to receive either both RAGT and traditional physical therapy or only traditional physical therapy. Their gait and functional performance will be assessed during the study period.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Trial of Robot-assisted-gait-training (RAGT) in Stroke Patients
NCT02694302
Effects of Intensive Robot-assisted Therapy in Patients With Subacute Stroke
NCT01767480
Therapeutic Effects of Robotic Exoskeleton-Assisted Gait Re-habilitation and Predictive Factors of Significant Improvements in Stroke Patients
NCT05825144
Robot-Assisted Gait Therapy in the Subacute Phase of First Ischemic Stroke
NCT04910217
Efficacy of End-Effector Robot-Assisted Gait Training in Subacute Stroke Patients
NCT03805009
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional PT
Conventional Physiotherapy
Physiotherapy
Participants in this group will receive conventional stroke rehabilitation therapy (including sit to stand, balance and gait training) 5 days/week, 30 minutes per session. Intervention Duration: 4 weeks.
Robotic Gait Training
Conventional Physiotherapy combined with Robotic Assistive Gait Training
Freewalk lower limb Robotic Assistive Gait Training
Participants in this group will receive robotic-assisted gait training three times per week (every other day) for 30 minutes per session, using the FREE Walk exoskeleton device (FREE Bionics, Taiwan). The device assists with walking, standing, and sitting. A physical therapist will help the participant wear the exoskeleton and supervise the training, adjusting the level of robotic support and intensity based on the participant's ability. In addition to RAGT, participants will receive conventional stroke rehabilitation therapy (including sit to stand, balance and gait training) on the remaining weekdays (2 days/week), 30 minutes per session.
Intervention Duration: 4 weeks.
Physiotherapy
Participants in this group will receive conventional stroke rehabilitation therapy (including sit to stand, balance and gait training) 5 days/week, 30 minutes per session. Intervention Duration: 4 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Freewalk lower limb Robotic Assistive Gait Training
Participants in this group will receive robotic-assisted gait training three times per week (every other day) for 30 minutes per session, using the FREE Walk exoskeleton device (FREE Bionics, Taiwan). The device assists with walking, standing, and sitting. A physical therapist will help the participant wear the exoskeleton and supervise the training, adjusting the level of robotic support and intensity based on the participant's ability. In addition to RAGT, participants will receive conventional stroke rehabilitation therapy (including sit to stand, balance and gait training) on the remaining weekdays (2 days/week), 30 minutes per session.
Intervention Duration: 4 weeks.
Physiotherapy
Participants in this group will receive conventional stroke rehabilitation therapy (including sit to stand, balance and gait training) 5 days/week, 30 minutes per session. Intervention Duration: 4 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subacute phase of stroke (onset within 1 to 3 months).
* Moderate to good standing balance ability.
* Sufficient cognitive ability to understand the study and follow instructions.
* Able to participate in rehabilitation training during the study period.
Exclusion Criteria
* Presence of other neurological disorders.
* Severe cardiovascular disease or other health conditions affecting mobility.
* Significant lower limb pain, joint contracture, or spasticity (Modified Ashworth Scale score \> 3) that impairs walking.
* Diagnosed with cardiopulmonary disease that contraindicates exercise training.
* Cognitive impairment that prevents understanding of training instructions or completion of questionnaires.
* Inability to complete the rehabilitation training protocol.
45 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Changhua Christian Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Su-Fen Liao
Role: PRINCIPAL_INVESTIGATOR
Changhua Christian Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Changhua Christian Hospital
Changhua, Taiwan, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Office of Human Subject Protection Changhua Christian Hospital
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
250321
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.